IRIS Accounts Production v24.3.0.553 07177693 Board of Directors 1.4.23 31.3.24 31.3.24 the provision of medical reporting services. 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh071776932023-03-31071776932024-03-31071776932023-04-012024-03-31071776932022-03-31071776932022-04-012023-03-31071776932023-03-3107177693ns15:EnglandWales2023-04-012024-03-3107177693ns14:PoundSterling2023-04-012024-03-3107177693ns10:Director12023-04-012024-03-3107177693ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107177693ns10:SmallEntities2023-04-012024-03-3107177693ns10:AuditExemptWithAccountantsReport2023-04-012024-03-3107177693ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107177693ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107177693ns10:FullAccounts2023-04-012024-03-3107177693ns10:Director22023-04-012024-03-3107177693ns10:RegisteredOffice2023-04-012024-03-3107177693ns5:RetainedEarningsAccumulatedLosses2023-03-3107177693ns5:RetainedEarningsAccumulatedLosses2022-03-3107177693ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-3107177693ns5:RetainedEarningsAccumulatedLosses2022-04-012023-03-3107177693ns5:RetainedEarningsAccumulatedLosses2024-03-3107177693ns5:RetainedEarningsAccumulatedLosses2023-03-3107177693ns5:CurrentFinancialInstruments2024-03-3107177693ns5:CurrentFinancialInstruments2023-03-3107177693ns5:ShareCapital2024-03-3107177693ns5:ShareCapital2023-03-3107177693ns5:OfficeEquipment2023-04-012024-03-3107177693ns5:OfficeEquipment2023-03-3107177693ns5:OfficeEquipment2024-03-3107177693ns5:OfficeEquipment2023-03-3107177693ns5:FinancialAssetsCostLessImpairment2024-03-3107177693ns5:FinancialAssetsCostLessImpairment2022-03-3107177693ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3107177693ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31
REGISTERED NUMBER: 07177693 (England and Wales)















REPORT OF THE DIRECTORS AND

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

4 J'S MEDICAL SERVICES LIMITED

4 J'S MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 07177693)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Company Information 1

Report of the Directors 2

Statement of Income and Retained Earnings 3

Balance Sheet 4

Notes to the Financial Statements 5


4 J'S MEDICAL SERVICES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: L A James
C D Cortez - James





REGISTERED OFFICE: Sutton House
27 Wilson Patten Street
Warrington
Cheshire
WA1 1PG





REGISTERED NUMBER: 07177693 (England and Wales)





ACCOUNTANTS: John Kerr - Chartered Accountants
110-114 Duke Stret
Liverpool
Merseyside
L1 5AG

4 J'S MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 07177693)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 MARCH 2024


The directors present their report with the financial statements of the company for the year ended 31 March 2024.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 April 2023 to the date of this report.

L A James
C D Cortez - James

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





L A James - Director


25 November 2024

4 J'S MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 07177693)

STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE YEAR ENDED 31 MARCH 2024

31.3.24 31.3.23
£    £   

TURNOVER 56,549 70,911

Administrative expenses 23,941 15,548
32,608 55,363

Other operating income 1,636 803
OPERATING PROFIT 34,244 56,166


Interest payable and similar expenses 2,313 348
PROFIT BEFORE TAXATION 31,931 55,818

Tax on profit 6,092 10,588
PROFIT FOR THE FINANCIAL YEAR 25,839 45,230

Retained earnings at beginning of year 25,812 20,082

Dividends (31,500 ) (39,500 )

RETAINED EARNINGS AT END OF YEAR 20,151 25,812

4 J'S MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 07177693)

BALANCE SHEET
31 MARCH 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,563 325
Investments 5 1,145 803
2,708 1,128

CURRENT ASSETS
Debtors 6 39,392 51,135
Cash at bank 957 2,622
40,349 53,757
CREDITORS
Amounts falling due within one year 7 22,509 28,911
NET CURRENT ASSETS 17,840 24,846
TOTAL ASSETS LESS CURRENT LIABILITIES 20,548 25,974

PROVISIONS FOR LIABILITIES 297 62
NET ASSETS 20,251 25,912

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 20,151 25,812
SHAREHOLDERS' FUNDS 20,251 25,912

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 25 November 2024 and were signed on its behalf by:





L A James - Director


4 J'S MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 07177693)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024


1. STATUTORY INFORMATION

4 J's Medical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Office equipment - 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Jointly controlled entities
Interests in jointly controlled entities are accounted for using the equity method of accounting. Under this method, the investment is initially recognised at the transaction price and is subsequently adjusted to reflect the investor's share of the net profit or loss, other comprehensive income and equity of the investee.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4 J'S MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 07177693)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


4. TANGIBLE FIXED ASSETS
Office
equipment
£   
COST
At 1 April 2023 7,306
Additions 1,673
At 31 March 2024 8,979
DEPRECIATION
At 1 April 2023 6,981
Charge for year 435
At 31 March 2024 7,416
NET BOOK VALUE
At 31 March 2024 1,563
At 31 March 2023 325

5. FIXED ASSET INVESTMENTS
Interest
in other
participating
interests
£   
COST
At 1 April 2023 803
Disposals (803 )
Share of profit/(loss) 1,145
At 31 March 2024 1,145
NET BOOK VALUE
At 31 March 2024 1,145
At 31 March 2023 803

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 38,901 51,135
Other debtors 491 -
39,392 51,135

4 J'S MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 07177693)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade creditors 6,316 4,567
Taxation and social security 14,507 22,964
Other creditors 1,686 1,380
22,509 28,911